0001628280-24-023668.txt : 20240515
0001628280-24-023668.hdr.sgml : 20240515
20240515191521
ACCESSION NUMBER: 0001628280-24-023668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Makela Jan
CENTRAL INDEX KEY: 0001951803
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41528
FILM NUMBER: 24953161
MAIL ADDRESS:
STREET 1: 500 W. MONROE STREET
CITY: CHICAGO
STATE: IL
ZIP: 60661
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GE HealthCare Technologies Inc.
CENTRAL INDEX KEY: 0001932393
STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 882515116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 WEST MONROE STREET
CITY: CHICAGO
STATE: IL
ZIP: 60661
BUSINESS PHONE: 833-735-1139
MAIL ADDRESS:
STREET 1: 500 WEST MONROE STREET
CITY: CHICAGO
STATE: IL
ZIP: 60661
FORMER COMPANY:
FORMER CONFORMED NAME: GE Healthcare Holding LLC
DATE OF NAME CHANGE: 20220603
4
1
wk-form4_1715814910.xml
FORM 4
X0508
4
2024-05-13
0
0001932393
GE HealthCare Technologies Inc.
GEHC
0001951803
Makela Jan
500 W. MONROE STREET
CHICAGO
IL
60661
0
1
0
0
CEO, Imaging
0
Common Stock, par value $0.01 per share
2024-05-13
4
M
0
20227
63.51
A
83575
D
Common Stock, par value $0.01 per share
2024-05-13
4
S
0
20227
81.57
D
63348
D
Common Stock, par value $0.01 per share
2024-05-15
4
M
0
8388
63.51
A
71736
D
Common Stock, par value $0.01 per share
2024-05-15
4
M
0
25472
75.30
A
97208
D
Common Stock, par value $0.01 per share
2024-05-15
4
M
0
33095
76.37
A
130303
D
Common Stock, par value $0.01 per share
2024-05-15
4
S
0
66955
81.54
D
63348
D
Employee Stock Option (right to buy)
63.51
2024-05-13
4
M
0
20227
0
D
2030-03-02
Common Stock, par value $0.01 per share
20227
8388
D
Employee Stock Option (right to buy)
63.51
2024-05-15
4
M
0
8388
0
D
2030-03-02
Common Stock, par value $0.01 per share
8388
0
D
Employee Stock Option (right to buy)
75.30
2024-05-15
4
M
0
25472
0
D
2033-03-01
Common Stock, par value $0.01 per share
25472
0
D
Employee Stock Option (right to buy)
76.37
2024-05-15
4
M
0
33095
0
D
2031-07-01
Common Stock, par value $0.01 per share
33095
33096
D
The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023.
Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024.
Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
2024-05-15